BiotechTube
Home/Cayuga Biotech/Samina Bari
SB

Samina Bari

Corporate and Business Affairs

Cayuga Biotech

Therapeutic Areas

Hemorrhage ControlCoagulation Disorders

Cayuga Biotech Pipeline

DrugIndicationPhase
CAY001Life-threatening Hemorrhage (e.g., trauma, surgery, anticoagulant-related)Pre-clinical

Leadership Team at Cayuga Biotech

AA
Andrea Ashford-Hicks
Chief Executive Officer
DK
Damien Kudela, PhD
Founder, Chief Science Officer
HB
Herb Brinkman, PhD
Head of CMC
HC
Holli Cherevka
Head of Clinical Operations
GL
Genmin Lu, PhD
Head of Translational Medicine
View full Cayuga Biotech profile